Staphylococcus IVDs

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Commercializzato da:

Cepheid Holdings Pty Ltd

Classe:

Class 3

Prodotto da:

Cepheid 904 Caribbean Drive, Sunnyvale, California, 94089 United States Of America

Area terapeutica:

CT797 - Staphylococcus IVDs

Indicazioni terapeutiche:

The Xpert MRSA and MRSA NxG, is a qualitative IVD for the detection of methicillin-resistant S. aureus DNA from nasal swabs. The test utilizes automated real-time PCR for the amplification of MRSA specific DNA targets. The Xpert MRSA and MRSA NxG is intended to aid in the prevention and control of MRSA infections in healthcare settings. The Xpert MRSA and MRSA NxG are not intended to diagnose, guide, or monitor treatment for MRSA infections, or provide results of susceptibility to methicillin

Stato dell'autorizzazione:

A

Data dell'autorizzazione:

2014-03-31